CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

76 hedge funds and large institutions have $142M invested in Cascadian Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$273K
Puts
$85K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$41M
2
$30.8M
3
$17.6M
4
$11.3M
5
$9.2M
6
$5.71M
7
$5.6M
8
$3.36M
9
$3.03M
10
$1.77M
11
$1.5M
12
$1.31M
13
$1.11M
14
$1.05M
15
$723K
16
$656K
17
$614K
18
$451K
19
$429K
20
$411K
21
$392K
22
$370K
23
$275K
24
$274K
25
$267K